WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (55)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chieng, B.
Right arrow Articles by Williams, J. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chieng, B.
Right arrow Articles by Williams, J. T.

 Previous Article  |  Next Article 

The Journal of Neuroscience, September 1, 1998, 18(17):7033-7039

Increased Opioid Inhibition of GABA Release in Nucleus Accumbens during Morphine Withdrawal

Billy Chieng and John T. Williams

The Vollum Institute, Oregon Health Sciences University, Portland, Oregon 97201

The nucleus accumbens is a key component of the reward pathway that plays a role in addiction to many drugs of abuse, including psychostimulants and opioids. The effects of withdrawal from chronic morphine were examined in the nucleus accumbens using brain slices from morphine-treated animals. Recordings were made from interneurons in the shell of nucleus accumbens, and the presynaptic inhibition of GABA-A IPSCs by opioids was examined. In slices from control animals, opioids caused a maximal inhibition of 50%, forskolin increased the IPSC amplitude by less than twofold, and the maximal inhibition by opioids in the presence of forskolin was not changed. During withdrawal, however, forskolin caused approximately a fourfold increase in the amplitude of the IPSC, and the maximal inhibition by opioids was increased to 80%. The results indicate that transmitter release is increased during opioid withdrawal, particularly after the activation of adenylyl cyclase. The cAMP-dependent increase in transmitter release is potently inhibited by opioids, such that the overall effect of opioids is augmented during withdrawal. The induction of an opioid-sensitive cAMP-dependent mechanism that regulates transmitter release may be a critical component of acute opioid withdrawal.

Key words: µ-opioid; adenosine; cAMP; adenylyl cyclase; electrophysiology; A-kinase


Copyright © 1998 Society for Neuroscience  0270-6474/98/18177033-07$05.00/0


This article has been cited by other articles:


Home page
J. Neurosci.Home page
R. Tonini, S. Ciardo, M. Cerovic, T. Rubino, D. Parolaro, M. Mazzanti, and R. Zippel
ERK-Dependent Modulation of Cerebellar Synaptic Plasticity after Chronic {Delta}9-Tetrahydrocannabinol Exposure
J. Neurosci., May 24, 2006; 26(21): 5810 - 5818.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
E. C. Dumont and J. T. Williams
Noradrenaline Triggers GABAA Inhibition of Bed Nucleus of the Stria Terminalis Neurons Projecting to the Ventral Tegmental Area
J. Neurosci., September 22, 2004; 24(38): 8198 - 8204.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
S. M. Nicola, I. A. Yun, K. T. Wakabayashi, and H. L. Fields
Firing of Nucleus Accumbens Neurons During the Consummatory Phase of a Discriminative Stimulus Task Depends on Previous Reward Predictive Cues
J Neurophysiol, April 1, 2004; 91(4): 1866 - 1882.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
P.-W. Lee and Y.-M. Lee
Transcriptional Regulation of {micro} Opioid Receptor Gene by cAMP Pathway
Mol. Pharmacol., December 1, 2003; 64(6): 1410 - 1418.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. A. Bolanos, L. I. Perrotti, S. Edwards, A. J. Eisch, M. Barrot, V. G. Olson, D. S. Russell, R. L. Neve, and E. J. Nestler
Phospholipase C{gamma} in Distinct Regions of the Ventral Tegmental Area Differentially Modulates Mood-Related Behaviors
J. Neurosci., August 20, 2003; 23(20): 7569 - 7576.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
J. M. Brundege and J. T. Williams
Differential Modulation of Nucleus Accumbens Synapses
J Neurophysiol, July 1, 2002; 88(1): 142 - 151.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. Akbarian, M. Rios, R.-J. Liu, S. J. Gold, H.-F. Fong, S. Zeiler, V. Coppola, L. Tessarollo, K. R. Jones, E. J. Nestler, et al.
Brain-Derived Neurotrophic Factor Is Essential for Opiate-Induced Plasticity of Noradrenergic Neurons
J. Neurosci., May 15, 2002; 22(10): 4153 - 4162.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
J. M. Harrison, R. G. Allen, M. J. Pellegrino, J. T. Williams, and O. J. Manzoni
Chronic Morphine Treatment Alters Endogenous Opioid Control of Hippocampal Mossy Fiber Synaptic Transmission
J Neurophysiol, May 1, 2002; 87(5): 2464 - 2470.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Melis, R. Camarini, M. A. Ungless, and A. Bonci
Long-Lasting Potentiation of GABAergic Synapses in Dopamine Neurons after a Single In Vivo Ethanol Exposure
J. Neurosci., March 15, 2002; 22(6): 2074 - 2082.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
J. M. Brundege and J. T. Williams
Increase in Adenosine Sensitivity in the Nucleus Accumbens Following Chronic Morphine Treatment
J Neurophysiol, March 1, 2002; 87(3): 1369 - 1375.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
D. Centonze, E. Saulle, A. Pisani, G. Bernardi, and P. Calabresi
Adenosine-mediated inhibition of striatal GABAergic synaptic transmission during in vitro ischaemia
Brain, September 1, 2001; 124(9): 1855 - 1865.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. A. Taylor and W. W. Fleming
Unifying Perspectives of the Mechanisms Underlying the Development of Tolerance and Physical Dependence to Opioids
J. Pharmacol. Exp. Ther., April 1, 2001; 297(1): 11 - 18.
[Abstract] [Full Text]


Home page
J. Neurophysiol.Home page
G. O. Hjelmstad and H. L. Fields
Kappa Opioid Receptor Inhibition of Glutamatergic Transmission in the Nucleus Accumbens Shell
J Neurophysiol, March 1, 2001; 85(3): 1153 - 1158.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
A. F. Hoffman and C. R. Lupica
Direct Actions of Cannabinoids on Synaptic Transmission in the Nucleus Accumbens: A Comparison With Opioids
J Neurophysiol, January 1, 2001; 85(1): 72 - 83.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
J. T. Williams, M. J. Christie, and O. Manzoni
Cellular and Synaptic Adaptations Mediating Opioid Dependence
Physiol Rev, January 1, 2001; 81(1): 299 - 343.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
G. Martin, S. H. Ahmed, T. Blank, J. Spiess, G. F. Koob, and G. R. Siggins
Chronic Morphine Treatment Alters NMDA Receptor-Mediated Synaptic Transmission in the Nucleus Accumbens
J. Neurosci., October 15, 1999; 19(20): 9081 - 9089.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
O. J. Manzoni and J. T. Williams
Presynaptic Regulation of Glutamate Release in the Ventral Tegmental Area During Morphine Withdrawal
J. Neurosci., August 1, 1999; 19(15): 6629 - 6636.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
E. E Bagley, C. W Vaughan, and M. J Christie
Inhibition by adenosine receptor agonists of synaptic transmission in rat periaqueductal grey neurons
J. Physiol., April 1, 1999; 516(1): 219 - 225.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Y. Shoji, J. Delfs, and J. T. Williams
Presynaptic Inhibition of GABAB-Mediated Synaptic Potentials in the Ventral Tegmental Area during Morphine Withdrawal
J. Neurosci., March 15, 1999; 19(6): 2347 - 2355.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. L. Ingram, C. W. Vaughan, E. E. Bagley, M. Connor, and M. J. Christie
Enhanced Opioid Efficacy in Opioid Dependence Is Caused by an Altered Signal Transduction Pathway
J. Neurosci., December 15, 1998; 18(24): 10269 - 10276.
[Abstract] [Full Text] [PDF]



-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-